Skip to main content
. 2020 May 29;10:101. doi: 10.1186/s13568-020-01038-y

Fig. 2.

Fig. 2

V9 treatment improves HFD-induced metabolic disorder. a Hepatic levels of TG. b Hepatic levels of FFA. c Hepatic levels of Glycogen. d Fasting glucose levels in serum. Data are expressed as mean ± SD with n = 8, **P < 0.01 vs HFD group